Luzu, an azole antifungal, is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton ...

The prevalence of tinea pedis in the studies ranged from 0.03% to 15.60%. The highest prevalence rates appeared in studies published after 2000. Dermatophytes accounted for 96% of infections, ...

Tinea unguium, tinea pedis, and tinea corporis were the most common infections, comprising 20.5%, 12.2%, and 12.0% of the total visits, respectively.

In the double-blind trial, SB208 was evaluated in 222 patients with tinea pedis, who were randomly assigned to one of three active or vehicle treatment arms, applying either SB208 Gel (2%, 4% or ...